Published in Women's Health Weekly, September 30th, 2004
P. Lind and colleagues, LKH Klagenfurt, PET CT Center, wrote: "18F-Fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) has been evaluated in breast cancer for the characterization of primary tumors, lymph node staging, and the follow-up of patients after surgery, chemotherapy, and/or external radiotherapy.
"In contrast to both the low sensitivity and moderate specificity of FDG PET in the initial detection and characterization of breast cancer and the low...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly